Related Experiment Video
Updated: Jan 14, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Inulin aggravates colitis through gut microbiota modulation and MyD88/IL-18 signaling
Xu Zhao1, Yadong Wang1, Yanling Wang1
1Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
None:
Different types of dietary fibers exert distinct effects on gut microbiota and overall health, playing a complex role in disease-specific contexts. Here, we found that while supplementation with dietary soluble fiber inulin does not induce inflammation under steady-state conditions, it exacerbates intestinal inflammation in a DSS-induced colitis mouse model in a gut microbiota-dependent manner. Mechanistically, we found that inulin consumption increases the overall bacterial load with expansion of pro-colitis pathobiont, elevates levels of pro-inflammatory component flagellin, and reduces microbial diversity. These microbiota changes drove colitis aggravation via GR-1⁺ cell-mediated inflammation. Using NLRC4/TLR5- and MyD88-deficient mice, we identified microbiota-derived pro-inflammatory signals-particularly flagellin-as key mediators of this effect. Moreover, the exacerbation of colitis was abolished in IL-18 knockout mice, indicating a critical role for inflammasome signaling in mediating this response. Notably, maternal consumption of an inulin-enriched diet during lactation altered the offspring's gut microbiota and increased their susceptibility to DSS-induced colitis. Collectively, our findings suggest that inulin intake exacerbates DSS induced colitis through microbiota-mediated inflammation and MyD88/IL-18 signaling, with the effects persist in the offspring. These results underscore the importance of considering fiber type in disease-specific dietary interventions, supporting the idea that a more balanced intake of natural dietary fibers that foster a diverse and resilient gut microbiota may offer greater benefits for intestinal health.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents